Mufg Securities Emea PLC Ionis Pharmaceuticals Inc Transaction History

Mufg Securities Emea PLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$29.88 - $37.04 $5.98 Million - $7.41 Million	-200,000 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$25.61 - $35.1 $5.12 Million - $7.02 Million	200,000 New	200,000 $6.09 Million
Q4 2020 Feb 11, 2021	SELL	$45.3 - $60.27 $560,542 - $745,780	-12,374 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$47.45 - $62.95 $587,146 - $778,943	12,374 New	12,374 $587,000
Q3 2019 Nov 12, 2019	SELL	$59.06 - $72.15 $2.78 Million - $3.4 Million	-47,111 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$52.92 - $81.17 $2.49 Million - $3.82 Million	47,111 New	47,111 $3.82 Million

389

125M

2.25M

510K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.64B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Mufg Securities Emea PLC, based on Form 13F filings with the SEC.

Stay updated on Mufg Securities Emea PLC with notifications on news.